Cardiovascular effects of mexiletine for treatment of myotonia in myotonic dystrophy type 1

Autor:	María Valverde-Gómez, Cristina Domínguez-González, Rafael Salguero-Bodes, Aníbal Ruiz-Curiel, Julián Palomino-Doza, Fernando Arribas-Ynsaurriaga
Rok vydání:	2021
Předmět:	business.industry Mexiletine medicine General Medicine Myotonia medicine.disease Bioinformatics business Myotonic dystrophy medicine.drug
Zdroj:	Revista Española de Cardiología (English Edition). 74:986-987
ISSN:	1885-5857
DOI:	10.1016/j.rec.2021.04.016
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::dfc7de8f1a5bb044b673abbf69f0b67d https://doi.org/10.1016/j.rec.2021.04.016 Zobrazit plný text záznamu Full Text from ScienceDirect